GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 783 filers reported holding GLAXOSMITHKLINE PLC in Q2 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $264,000 | -21.0% | 6,067 | -30.7% | 0.02% | -37.8% |
| Q4 2018 | $334,000 | -4.8% | 8,750 | 0.0% | 0.04% | +12.1% |
| Q3 2018 | $351,000 | -9.8% | 8,750 | -9.3% | 0.03% | -10.8% |
| Q2 2018 | $389,000 | +10.8% | 9,650 | +7.5% | 0.04% | +5.7% |
| Q1 2018 | $351,000 | +10.4% | 8,977 | 0.0% | 0.04% | +12.9% |
| Q4 2017 | $318,000 | -10.4% | 8,977 | +2.6% | 0.03% | -13.9% |
| Q3 2017 | $355,000 | +13.4% | 8,750 | +20.7% | 0.04% | +9.1% |
| Q2 2017 | $313,000 | +2.3% | 7,250 | 0.0% | 0.03% | 0.0% |
| Q1 2017 | $306,000 | +22.4% | 7,250 | +11.5% | 0.03% | +17.9% |
| Q4 2016 | $250,000 | -17.8% | 6,500 | -7.7% | 0.03% | -17.6% |
| Q3 2016 | $304,000 | -0.3% | 7,040 | 0.0% | 0.03% | 0.0% |
| Q2 2016 | $305,000 | -9.2% | 7,040 | -14.9% | 0.03% | -10.5% |
| Q1 2016 | $336,000 | +52.0% | 8,274 | +72.4% | 0.04% | +31.0% |
| Q3 2012 | $221,000 | – | 4,800 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |